Lutsine is a dermo-cosmetic brand that is part of the extensive portfolio of the Swedish consumer healthcare company Karo Pharma. It offers a range of products for various skin types and conditions, including sensitive, dry, atopic, oily, and baby skin.

Company Structure & History

Current Owner:
Lutsine is currently owned by Karo Pharma, a company headquartered in Stockholm, Sweden, which acquired the brand in 2022 as part of a transaction involving the E45 brand and related sub-brands from the British multinational consumer goods company, Reckitt.

Previous Ownership:
Reckitt had acquired the Lutsine brand as part of its purchase of Boots Healthcare International in 2005.

Focus:
Karo Pharma focuses on commercial operations in major European markets and the acquisition of science-backed skin health brands, making Lutsine a key part of its dermatology portfolio.

Products and Focus

Lutsine specializes in hypoallergenic and dermatologically tested products, often free of perfumes and parabens. Its product lines include:

Eryplast:
A well-known line of water-based pastes and creams containing zinc oxide designed to soothe and protect a baby’s delicate skin from diaper rash and irritation.

Xeramance:
Products aimed at intense, long-lasting hydration and restoring the skin barrier for very dry and atopic skin in adults, infants, and children.

Bactopur/Bactostop:
Products, such as cleansing gels and facial treatments, for acne-prone skin with imperfections.